NCT06992258
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06992258
Title A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer (FRUITION)
Acronym FRUITION
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Criterium, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Yale University RECRUITING New Haven Connecticut 06520 United States Details
Mount Sinai Cancer Research Program RECRUITING Miami Beach Florida 33140 United States Details
Orlando Health Cancer Institute RECRUITING Orlando Florida 32806 United States Details
Rutgers Cancer Institute RECRUITING New Brunswick New Jersey 08903 United States Details
NYU Langone Health RECRUITING New York New York 10016 United States Details
UPenn Lancaster-Ann B. Barshinger Cancer Institute RECRUITING Lancaster Pennsylvania 17601 United States Details
Vanderbilt University Medical Center RECRUITING Nashville Tennessee 37232 United States Details
Mays Cancer Center at University of Texas Health at San Antonio RECRUITING San Antonio Texas 78229 United States Details
Inova Schar Cancer RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field